ADVFN - Advanced Financial Network.
HOME» NYSE » B » BSX Stock Price » BSX Stock News

Boston Scientific Share News

 Boston Scientific Corp. Stock Price
BSX Stock Price
 Boston Scientific Corp. Stock Chart
BSX Stock Chart
 Boston Scientific Corp. Stock News
BSX Stock News
 Boston Scientific Corp. Company Information
BSX Company Information
 Boston Scientific Corp. Stock Trades
BSX Stock Trades

Boston Scientific CEO Kucheman's 2011 Total Pay Rose 47% To $4.7 Million

By Anjali Athavaley Of DOW JONES NEWSWIRES NEW YORK -(Dow Jones)- Boston Scientific Corp. (BSX) Chief Executive William H. Kucheman's total pay jumped 47% to $4.7 million last year after he was named interim head of the Natick, Mass., medical-device maker. President Michael F. Mahoney, Kucheman's eventual replacement, received total compensation valued at $11.7 million last year, according to a filing Thursday with the Securities & Exchange Commission. Last fall, the company named Mahoney, previously the world-wide chairman of rival Johnson & Johnson's (JNJ) medical device and diagnostics group, as its new CEO in a complicated arrangement. Under the plan, Mahoney joined Boston Scientific as president in October and is expected to become CEO Nov. 1 this year. Kucheman, formerly president of the company's cardiology, rhythm and vascular group, is serving as interim CEO until then. Boston Scientific said in a regulatory filing last fall Mahoney would get an annual salary of $900,000 plus a sign-on bonus of $1.5 million and an additional bonus of $750,000 to be paid within 30 days following his promotion to president and CEO. He also would receive $9.5 million in deferred stock. As interim CEO, Kucheman would receive an annual salary of $900,000, the company has said. Shares were unchanged after-hours after closing up 3.5% at $5.93 Thursday. -By Anjali Athavaley, Dow Jones Newswires; 212-416-4912; anjali.athavaley@dowjones.com

Stock News for Boston Scientific (BSX)
DateTimeHeadline
12/02/201607:00:00Boston Scientific Announces Agreement to Acquire Neovasc Advanced...
11/28/201618:25:00Nevro Files Lawsuit for Patent Infringement Against Boston Scientific...
11/23/201608:30:00Boston Scientific To Participate In Citi 2016 Global Healthcare...
11/22/201616:17:14Current Report Filing (8-k)
11/22/201608:36:00Boston Scientific Closes EndoChoice Acquisition
11/21/201607:00:00Boston Scientific Receives 2016 Shingo Prize for Operational...
11/16/201616:30:00Boston Scientific To Participate In Piper Jaffray 2016 Healthcare...
11/16/201613:34:00Boston Scientific Announces Positive Results Of HeartLogic™ H...
11/15/201606:30:00Boston Scientific Acquires Resectr™ Tissue Resection Device f...
11/04/201606:30:00Boston Scientific Announces Extension of the Cash Tender Offer...
11/03/201616:56:21Statement of Changes in Beneficial Ownership (4)
11/03/201616:51:34Statement of Changes in Beneficial Ownership (4)
11/03/201616:14:20Quarterly Report (10-q)
11/03/201606:30:00Boston Scientific Announces Acquisition Of The LumenR™ Tissue R...
11/02/201609:43:00Boston Scientific Announces Initial U.S. Commercial Performance...
11/02/201608:45:00The Shift of Medical Devices to a Home Setting
11/01/201616:11:05Statement of Changes in Beneficial Ownership (4)
11/01/201613:11:00Primary Endpoint from Study of Drug Eluting Coronary Stent in...
10/31/201609:00:00The Growth in Medical Device and Technology Markets
10/27/201616:42:09Statement of Changes in Beneficial Ownership (4)

Boston Scientific and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US